Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-05-17 @ 5:44 PM
Study NCT ID:
NCT01833520
Status:
COMPLETED
Last Update Posted:
2021-02-02
First Post:
2013-04-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Sarcoma | View |